FDA Investigator Karishma G Gopaul

Karishma G Gopaul has conducted inspections on 19 sites in 1 countries as of 13 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
19
Last Inspection Date:
13 May 2024
Investigator Role:
FDA Investigator
Redica ID:
100007559
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Karishma G Gopaul:
Addam S Reynolds, Adena S Yau, Adetutu M Gidado, Alice S Tsao, Althea A Williams, Amatul H Marium, Amy M Codella, Amy M Cramer, Ankur C Patel, Annemarie Bodnar, Anthony J Donato, Arduino Frankovic, Ashutosh Rao, PhD, Barbara Jwilimczyk Macri, Bijoy Panicker, Camerson E Moore, Charisse K Green, Daniel J Grabicki, Daniel L Zheng, David A Oluwo, David R Delucia, Deborah J Parris, Demitria J Xiradakis, Dipesh K Shah, Donald C Obenhuber, PhD, Dongping Dai, PhD, Douglas C Kovacs, Dr. Robert C Horan, MD, Edmund F Mrak, Jr, Emmanuel Jramos Maldonado, Emmanuel T Donyina, Felix Maldonado, Frederick F Razzaghi, Gam S Zamil, Ganesh N Joshi, Gary J Lehr, Gary T Greco, Guerlain Ulysse, Helen Verdel, Himanshu Gupta, PhD, Jacqueline S Warner, James A Liubicich, James M Mason, James R Birkenstamm, Janet A Rajan, Jay B Shah, Jazmine N Brown, Jenny Sung, Jill M Sooter, Jill Mielziner, Jogy George, John P Mistler, Jonah S Ufferfilge, Jose Acruz Gonzalez, Jose M Cayuela, Jose Ohernandez Guzman, Josh Renzo N Ramilo, Juliana M Badalucco, Junho Pak, Justine Tomasso, Karen E D'orazio, Karl Auguste, Kelli F Dobilas, Kenneth H Williams, Kevin A Gonzalez, Kim Lthomas Cruse, Ko U Min, Kristy A Zielny, Lane V Christensen, PhD, Larry Johnson, Lata C Mathew, PhD, Lauren L Vajo, Lawrence R Johnson, Lawrence W Farina, Li Li, Maotang Zhou, PhD, Marea K Harmon, Margaret M Sands, Maria Estrella, Matthew A Spataro, Meredith L Sheridan, Michael L Casner, Michael R Klapal, Michael Serrano, Mindy M Chou, Nancy F Scheraga, Nancy M Espinal, Neil J Bonzagni, PhD MPH, Nerizza B Guerin, Nicholas A Violand, Niketa Patel, Parul M Patel, Paul L Bellamy, Paul Mouris, Peter Abel, Peter Caparelli, Peter R Caparelli, Puspa Suresh Jayasekara, Rachael A Moliver, Raihan A Chowdhury, Regina T Brown, Robert C Steyert, Robert J Martin, Robin P Mathew, Rochelle K Kimmel, Ronald Ifraimov, Rose Ljean Mary, Russell J Glapion, Saleem A Akhtar, Samir C Gala, Samuel J Arsenault, Sandra A Boyd, Sayyem H Akbar, Sean G Casey, Sean R Marcsisin, Sena G Dissmeyer, Shirley S Wen, Sony Mathews, Srinivas R Chennamaneni, PhD, Sripal R Mada, PhD, Stacey S Degarmo, Suchan Kim, Tara G Bizjak, Tara K Carmody, Tara R Gooen, Thomas J Mooney, Tonia F Bernard, Uduak M Inokon, Unnee Ranjan, Victoria Spivak, Vivin George, Wayne E Seifert, Xikui Chen (nmi), PhD, Yvesna C Blaise

Karishma G Gopaul's Documents

Publish Date Document Type Title
August, 2022 FDA 483 Fougera Pharmaceuticals Inc. - Form 483, 2022-08-10
March, 2023 FDA 483 EzriCare, LLC. - Form 483, 2023-03-21
March, 2023 FDA 483 Maimonides Medical Center - Pharmacy - Form 483, 2023-03-09
January, 2023 FDA 483 Novel Laboratories, Inc. - Form 483, 2023-01-13
August, 2023 FDA 483 Accuon Labs Inc. - Form 483, 2023-08-31
January, 2024 FDA 483 Pharmalogic New York City, LLC - Form 483, 2024-01-12
June, 2023 EIR Renaissance Lakewood LLC - EIR, 2023-06-06
September, 2022 FDA 483 ScieGen Pharmaceuticals INC - Form 483, 2022-09-02
September, 2023 FDA 483 InvaGen Pharmaceuticals, Inc - Form 483, 2023-09-19
August, 2023 FDA 483 Sciarra Laboratories, Inc. - Form 483, 2023-08-07
June, 2023 FDA 483 Renaissance Lakewood LLC - Form 483, 2023-06-06
November, 2022 FDA 483 Amneal Pharmaceuticals, LLC - Form 483, 2022-11-18
May, 2024 FDA 483 Lyophilization Services Of New England, Inc. (LSNE) - Form 483, 2024-05-24
September, 2022 FDA 483 Scully's Wonderful Stuff Inc. - Form 483, 2022-09-15
August, 2024 FDA 483 ProRx LLC - Form 483, 2024-08-02
August, 2022 FDA 483 Fougera Pharmaceuticals Inc. - Form 483, 2022-08-10
September, 2024 FDA 483 H. W. Naylor Company Inc. - Form 483, 2024-09-26

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more